STATCenter·
STAT+: FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease
The FDA approved a new gene therapy for Sanfilippo syndrome type A, an ultra-rare disease sometimes known as childhood Alzheimer’s.
Read at STAT →
The FDA approved a new gene therapy for Sanfilippo syndrome type A, an ultra-rare disease sometimes known as childhood Alzheimer’s.

<iframe src="https://statesidedaily.com/embed/cluster/151ed066097c2c098d22bc14a376cc3221d30d83" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease"></iframe>
